Target intelligence / Profile preview

NAMPT antisense RNA 1 (NAMPT-AS1)

Target
NAMPT-AS1
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

NAMPT antisense RNA 1 (*NAMPT-AS1*) is a long non-coding RNA gene transcribed antisense to the *NAMPT* gene locus. Unlike *NAMPT*, which encodes an enzyme critical for NAD+ biosynthesis and implicated in metabolic regulation and disease, *NAMPT-AS1* does not encode a protein and is not classified as a therapeutic target. Its primary annotation is as a lncRNA, a class of molecules generally involved in the post-transcriptional and epigenetic regulation of gene expression. There is currently limited functional or disease-related data specifically on *NAMPT-AS1*. It is important not to confuse *NAMPT-AS1* with *NAMPT* (nicotinamide phosphoribosyltransferase), which is a drug target and is involved in pathways such as cancer metabolism, inflammation, and aging[3][4][7]. Clarification: There is nothing misspelled or inherently incorrect in the provided target information. However, there is often confusion in literature searches between *NAMPT-AS1* (lncRNA) and *NAMPT* (protein/enzyme target)[3]. If you are interested in the enzyme/protein target (NAMPT), properties and drug associations differ substantially.

Other names
AC007032.1PBEF antisense RNAH_NH0022N19_gi18089094.sp_cds.1NAMPT-AS1
02

Biological functions

Gene expression regulation (inferred from general lncRNA function; specific functions of *NAMPT-AS1* are largely uncharacterized in current databases)
03

Disease associations

Other (potential involvement as a regulatory RNA; no direct evidence of strong disease association for *NAMPT-AS1* itself in currently referenced databases)

Beyond the preview

Go deeper on NAMPT antisense RNA 1 (NAMPT-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAMPT antisense RNA 1 (NAMPT-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call